Skip to main content
Supplement Research and Comparison WebsiteBest Price GuaranteeAbout Us
Supplement Research and Comparison Website

Abstract

A feeding trial was conducted to investigate the effects of dietary administration of probiotic Bacillus subtilis and prebiotic fructooligosaccharide (FOS) on growth performance, immune responses and disease resistance of juvenile ovate pompano, Trachinotus ovatus. One thousand six hundred and twenty individuals (initial body weight: 10.32 ± 0.46 g, mean ± S.E) were fed nine practical diets according to a 3 × 3 factorial design: the basal diet as the control diet supplemented with three levels of B. subtilis (0, 1.05 × 10(7) or 5.62 × 10(7) CFU g(-1) diet), crossed with 0, 0.2% or 0.4% FOS. After an 8-week feeding experimental period, six fish per cage were sampled for immunity determination. Then 18 fish of each cage left were challenged by Vibrio vulnificus. The results showed that fish fed with 5.62 × 10(7) CFU B. subtilis g(-1) in combination with 0.2% FOS produced the highest specific growth rate, and were significantly higher than the groups fed with 0 and 0.2% FOS without B. subtilis supplementation (P < 0.05). Feed efficiency ratio significantly increased with the increasing doses of dietary FOS without B. subtilis added (P < 0.05). The immune assay showed that fish fed with the control diet produced the lowest respiratory burst activity and was significantly different from the groups fed the diets containing 0.2% FOS at each B. subtilis level and containing 0.4% FOS single (P < 0.05). Phagocytic activity was significantly decreased with the increasing doses of dietary B. subtilis at 0.4% FOS level (P < 0.05). Alternative complement pathway activity of the fish fed with 0.2% FOS single was significantly lower than those fed with 5.62 × 10(7) CFU B. subtilis g(-1) diet supplemented at each FOS level (P < 0.05). Fish fed with the control diet had the lowest lysozyme activity, and were significantly different from those fed with 0.2 or 0.4% FOS at 1.05 and 5.62 × 10(7) CFU B. subtilis g(-1) diet level. Moreover, fish fed with diets supplemented with 0.2% and 0.4% FOS at each B. subtilis level had notably lower cumulative mortality after 10 days following V. vulnificus infection (P < 0.05). Under the experimental conditions, dietary B. subtilis and FOS had a significant interaction on enhancing the immune responses and disease resistance of juvenile ovate pompano (P < 0.05).

Keywords: Immunity; Prebiotic; Probiotic; Trachinotus ovatus; Vibrio vulnificus.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Bacillus SubtilisEnhanced Respiratory Burst ActivityBeneficial
Moderate
Bacillus SubtilisImproved Feed EfficiencyBeneficial
Moderate
Bacillus SubtilisImproved Growth PerformanceBeneficial
Large
Bacillus SubtilisImproved Phagocytic ActivityBeneficial
Moderate
Bacillus SubtilisIncreased Complement Pathway ActivityBeneficial
Moderate
Bacillus SubtilisIncreased Serum Lysozyme ActivityBeneficial
Moderate
Bacillus SubtilisReduced Cumulative Mortality from Vibrio vulnificusBeneficial
Large
Bacillus subtilis AB22Enhanced Complement Pathway ActivityBeneficial
Moderate
Bacillus subtilis AB22Enhanced Respiratory Burst ActivityBeneficial
Moderate
Bacillus subtilis AB22Improved Feed EfficiencyBeneficial
Moderate
Bacillus subtilis AB22Improved Growth RateBeneficial
Large
Bacillus subtilis AB22Increased Serum Lysozyme ActivityBeneficial
Moderate
Bacillus subtilis AB22Reduced Mortality Post-InfectionBeneficial
Large
Bacillus subtilis AB22Reduced Phagocytic ActivityHarmful
Small
Bacillus subtilis DE111Enhanced Disease ResistanceBeneficial
Large
Bacillus subtilis DE111Improved Growth PerformanceBeneficial
Large
Bacillus subtilis DE111Improved ImmunityBeneficial
Large
Bacillus subtilis SNZ-1972Enhanced Disease ResistanceBeneficial
Large
Bacillus subtilis SNZ-1972Enhanced Immune ResponseBeneficial
Large
Bacillus subtilis SNZ-1972Improved Feed EfficiencyBeneficial
Moderate
Bacillus subtilis SNZ-1972Improved Growth PerformanceBeneficial
Large
⬆ Back to top
Unsubscribe anytime. See our Privacy Policy.
Pillser
Supplement Research and Comparison Website: evidence-based information about supplements, their benefits, potential risks, and their efficacy.
Join Our Community
Statements on this website have not been reviewed by the U.S. Food and Drug Administration. These products are not meant to diagnose, treat, cure, or prevent any disease. The information here is not a replacement for personal medical advice.